Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Silo Pharma Inc (OP: SILO )

0.1305 UNCHANGED
Streaming Delayed Price Updated: 2:40 PM EDT, Aug 16, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 16,000
Open 0.1318
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1305
Today's Range 0.1305 - 0.1330
52wk Range 0.0892 - 0.2489
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Second Psychedelics Initiative Fails to Qualify for Colorado Ballot
Via Investor Brand Network
PsychedelicNewsBreaks – Silo Pharma Inc.’s (SILO) Ketamine Study Generates ‘Extremely Promising’ Data
Via Investor Brand Network

Performance

YTD
-1.88%
-1.88%
1 Month
+0.38%
+0.38%
3 Month
-10.06%
-10.06%
6 Month
-23.46%
-23.46%
1 Year
-24.22%
-24.22%

More News

Read More
Study Finds Smells Experienced in Nature Boost Mental Health
Via Investor Brand Network
Leading Neuroscientist Explains How Psychedelics Alters the Brain
Via Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO) Reports Positive Results from Research on Novel Liposomes
Via Investor Brand Network
Homing Peptides: Silo Pharma Inc. (SILO) Targets ADRs
Via Investor Brand Network
Three Clinical Trials On Psychedelic Microdosing Worth Following
Via Investor Brand Network
Silo Pharma Inc.’s (SILO) Ketamine Study Produces Positive Endpoint Results, Suggests Topical Formulation Reduces Neuropathic Nerve Pain
Via Investor Brand Network
Research Finds That Tourism, Travel May Boost Mental Health
Via Investor Brand Network
The DEA Rescinds Proposal to Ban Five Psychedelics
Via Investor Brand Network
Preclinical Ketamine Trial Shows Positive Results For Pain Conditions Like Fibromyalgia And Arthritis
Via Benzinga
Measure to Legalize Psychedelics Qualifies for November Ballot in Colorado
Via Investor Brand Network
PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) Reports Positive Results from Study Evaluating Topically Administered Ketamine Formulation
Via Investor Brand Network
Silo Pharma Announces Positive Results from its Topically Administered Formulation of Ketamine
From Silo Pharma, Inc.
Via Globe NewsWire
Study Highlights Concerns on Police Involvement in Emergency Mental Health Transfers
Via Investor Brand Network
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders
Via FinancialNewsMedia
Topics Law Enforcement
Exposures Legal
Silo Pharma Inc. (SILO) Produced Initial Liposome Batch for Rheumatoid Arthritis Study
Via Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO), UMB Collaborating on Potentially Significant Homing-Peptide Technology
Via Investor Brand Network
Study Says Ayahuasca Users Tend to Exercise More, Eat Healthier
Via Investor Brand Network
Topics Religion
Exposures Religion
Study Finds That Microdosing Psilocybin Mushrooms Improves Mood, Mental Health
Via Investor Brand Network
Study Maps How Brain Changes During Treatment for Depression
Via Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO) Announces Positive Results of New Study
Via Investor Brand Network
DEA Sets Hearing Date Regarding Plan to Ban Several Psychedelics
Via Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO) Bringing Hope, Possible Therapeutic to Alzheimer’s Patients
Via Investor Brand Network
Federal Health Agencies Admit That Classification of Psychedelics Is Impeding Research
Via Investor Brand Network
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.